USA: A confidentiality agreement shows potential coronavirus vaccine candidates were transferred from Moderna to the University of North Carolina in 2019, nineteen days prior to the official emergence of Covid-19 pandemic.
The confidentially agreement (read below) states that providers ‘Moderna’ alongside the ‘National Institute of Allergy and Infectious Diseases’ (NIAID) agreed to transfer ‘mRNA coronavirus vaccine candidates’ developed and jointly-owned by NIAID and Moderna to recipients ‘The University of North Carolina at Chapel Hill’ on the 12th December 2019.
The agreement was also signed by two representatives of the NIAID, one of whom was Amy F. Petrik PhD, a technology transfer specialist who signed the agreement on December 12th 2019 at 8:05 am.
The other signatory was Barney Graham MD PhD, an investigator for the NIAID, however this signature was not dated.
The final signatories on the agreement were Sunny Himansu, Moderna’s Investigator, and Shaun Ryan, Moderna’s Deputy General Councel. Both signautres were made on December 17th 2019.
All of these signatures were made prior to any knowledge of the emergence of the novel coronavirus. It wasn’t until December 31st 2019 that the World Health Organisation (WHO) became aware of an alleged cluster of viral pneumonia cases in Wuhan, China.
But even at this point they had not determined that an alleged new coronavirus was to blame, instead stating the pneumonia was of “unknown cause”.
It was not until January 9th 2020 that the WHO reported Chinese authorities had determined the outbreak was due to a novel coronavirus which later became known as SARS-CoV-2 with the resultant disease dubbed COVID-19.
So why was an mRNA coronavirus vaccine candidate developed by Moderna being transferred to the University of North Carolina on December 12th 2019?
Perhaps Moderna and the National Institute of Allergy and Infectious Diseases would like to explain themselves in a court of law?